top of page
Image-empty-state_edited.png

George McColgan

George is pioneering the next generation of vascular bypass grafts through advanced tissue engineering technology.

Team:
Founder: George McColgan


Studied:

Bachelor of Science (Hons), Neuroscience, UWA, 2016-2021

Doctor of Philosophy - PhD, Vascular Tissue Engineering, UWA, 2022-2026


Bio:

A PhD Candidate at the University of Western Australia (UWA), George is no stranger to solving or researching a problem. His zeal to provide a better way to heal found him in a unique position when he joined our 2025 cohort. George is striving to make a change for the better, not just locally but hopefully, eventually, globally.


Industry:
MedTech · Vascular Tissue Engineering


What They Do:
The company is developing an engineered vascular graft solution that aims to provide safer, more durable, and more accessible alternatives to traditional bypass grafts. Regenevess is focused on improving long-term outcomes for patients requiring vascular surgery through innovation at the intersection of biomaterials and regenerative medicine.


Contact:
🔗 https://www.linkedin.com/in/george-mccolgan-b70195222/

bottom of page